Center for Substance Abuse Prevention; Notice of Meeting, 23191-23192 [E9-11427]

Download as PDF 23191 Federal Register / Vol. 74, No. 94 / Monday, May 18, 2009 / Notices Description: The Federal Office of Child Support Enforcement (OCSE) is implementing the Federal Parent Locator Service (FPLS) Child Support Services Portal (FCSSP) for users of the FPLS to access online web applications. The portal Registration Process will provide OCSE, States, employers and multistate financial institutions the ability to create a secure account to view data for their respective applications. In order for users to access the portal, registration is required. Respondents: OCSE, Employers, Multistate Financial Institutions and State Child Support Agencies. ANNUAL BURDEN ESTIMATES Instrument Number of respondents Number of responses per respondent Average burden hours per response Total burden hours Registration Screens: Employers, Financial Institutions and State Child Support Agencies ............................................................................................... 520 1 0.10 52 cprice-sewell on PRODPC61 with NOTICES Estimated Total Annual Burden Hours: 52. In compliance with the requirements of Section 506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and Families is soliciting public comment on the specific aspects of the information collection described above. Copies of the proposed collection of information can be obtained and comments may be forwarded by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L’Enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. E-mail address: infocollection@acf.hhs.gov. All requests should be identified by the title of the information collection. The Department specifically requests comments on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. Dated: May 13, 2009. Janean Chambers, Reports Clearance Officer. [FR Doc. E9–11495 Filed 5–15–09; 8:45 am] BILLING CODE 4184–01–P VerDate Nov<24>2008 14:36 May 15, 2009 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Drug Testing Advisory Board (DTAB) will meet on June 2 and 3, 2009. The meeting is open to the public and will include discussion of the Mandatory Guidelines for Federal Workplace Drug Testing Programs, including implementation of the revised Mandatory Guidelines; Federal drug testing updates from the Department of Transportation, the Department of Defense, and the Nuclear Regulatory Commission; review of significant changes in the revised Mandatory Guidelines; and presentations on immunoassay kit issues, proficiency testing practice sets and rounds, instrumented initial test facilities, urine collector/collection site procedures, and Medical Review Officer training and certification. There will also be updates on a revised Federal custody and control form and expanded confirmatory drug test technologies. DTAB members and invited presenters will participate in this meeting through remote internet connection. On-site attendance by the public will be limited to space available. The meeting can also be accessed by the public via teleconference. To obtain teleconference call-in numbers and access codes, to make arrangements to attend on-site, or to request special accommodations for persons with disabilities, please communicate with DTAB’s Program Assistant, Ms. Giselle Hersh (see contact information below). SAMHSA would like to ensure that advisory committee meetings proceed in PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 an orderly fashion, are conducted in a safe and secure environment, that the right of free speech is protected, and that the ability of SAMHSA Advisory Committees to accomplish their objectives is not disrupted. Therefore, the following procedures will be followed at all DTAB meetings: • Attendees are subject to security screening, including identification (driver’s license) review, metal detector screening, and inspection of briefcases, packages, etc. Each attendee will be issued a security badge that must be worn at all times while in the building. • Any interested person who wishes to be assured of the right to make an oral presentation during the Public Comment portion of the DTAB meeting must register with Ms. Hersh before the meeting. • Those who have not registered before the meeting will only be invited to speak at the discretion of the Chair and should submit their request to the Designated Federal Official on the day of the meeting. • Public Comment participants who are designated to speak may be questioned only by the Chair or DTAB members. • Audience members may not present comments or questions to DTAB members unless recognized by the Chair. • Attendees at the meeting are asked to maintain order and not display behavior that is disruptive to the meeting (i.e., shouting from the audience, loud outbursts). • We ask that attendees not approach the DTAB table area during the meeting without permission from the Chair or the Designated Federal Official. • The DTAB Chair or Designated Federal Official will note on the record any disruptive behavior and will ask the person to cease the behavior or else leave the meeting room. Substantive program information, a summary of the meeting, and a roster of DTAB members may be obtained as E:\FR\FM\18MYN1.SGM 18MYN1 23192 Federal Register / Vol. 74, No. 94 / Monday, May 18, 2009 / Notices soon as possible after the meeting, either by accessing the SAMHSA Committee Web site, https://www.nac.samhsa.gov/ DTAB/meetings.aspx, or by contacting Ms. Hersh. The transcript for the meeting will also be available on the SAMHSA Committee Web site within three weeks after the meeting. Committee Name: Substance Abuse and Mental Health Services Administration Drug Testing Advisory Board. Date/Time/Type: June 2, 2009 from 10 a.m. to 4:30 p.m. EDT: OPEN. June 3, 2009 from 10 a.m. to 1 p.m. EDT: OPEN. Place: Sugarloaf and Seneca Conference Rooms, 1 Choke Cherry Road, Rockville, Maryland 20857. Contact: Ms. Giselle Hersh, Program Assistant, SAMHSA Drug Testing Advisory Board, 1 Choke Cherry Road, Room 2–1042, Rockville, Maryland 20857, Telephone: 240– 276–2600, Fax: 240–276–2610, E-mail: Giselle.Hersh@samhsa.hhs.gov. Toian Vaughn, Committee Management Officer, Substance Abuse and Mental Health, Services Administration. [FR Doc. E9–11427 Filed 5–15–09; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings cprice-sewell on PRODPC61 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group; Neurological Sciences and Disorders C. Date: June 8–9, 2009 Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont Washington, DC, 2401 M Street, NW., Washington, DC 20037. Contact Person: William C. Benzing, PhD, Scientific Review Administrator, Scientific Review Branch, Division Of Extramural Research, NINDS/NIH/DHHS/Neuroscience VerDate Nov<24>2008 14:36 May 15, 2009 Jkt 217001 Center, 6001 Executive Boulevard, Suite 3208, MSC 9529, Bethesda, MD 20892, (301) 496–0660, benzingw@mail.nih.gov. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group; Neurological Sciences and Disorders A. Date: June 24, 2009 Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Ritz Carlton Hotel, 1150 22nd Street, NW., Washington, DC 20037. Contact Person: Richard D. Crosland, PhD, Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892–9529, 301–496–9223. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group; Neurological Sciences and Disorders B. Date: June 25–26, 2009. Time: 7 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: State Plaza Hotel, 2117 E Street, NW., Washington, DC 20037. Contact Person: Ernest W Lyons, PhD, Scientific Review Officer, Scientific Review Branch, NINDS/NIH/DHHS, Neuroscience Center, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892–9529, 301– 496–4056. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: May 12, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–11583 Filed 5–15–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review R13. Date: June 17, 2009. Time: 1 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call) Contact Person: Mary Kelly, Scientific Review Officer, Scientific Review Branch, National Inst. of Dental & Craniofacial Research, NIH 6701 Democracy Blvd., room 672, MSC 4878, Bethesda, MD 20892–4878, 301–594–4809, mary_kelly@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Dated: May 11, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–11486 Filed 5–15–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel—NIBIB Training 2009/10. Date: June 26, 2009. Time: 11 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Blvd., 242, Bethesda, MD 20892. (Virtual Meeting) Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer, 6707 Democracy Boulevard, Suite 957, Bethesda, MD 20892. 301–496–4773. zhour@mail.nih.gov. E:\FR\FM\18MYN1.SGM 18MYN1

Agencies

[Federal Register Volume 74, Number 94 (Monday, May 18, 2009)]
[Notices]
[Pages 23191-23192]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11427]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Drug Testing Advisory Board (DTAB) will meet on June 2 and 3, 2009.
    The meeting is open to the public and will include discussion of 
the Mandatory Guidelines for Federal Workplace Drug Testing Programs, 
including implementation of the revised Mandatory Guidelines; Federal 
drug testing updates from the Department of Transportation, the 
Department of Defense, and the Nuclear Regulatory Commission; review of 
significant changes in the revised Mandatory Guidelines; and 
presentations on immunoassay kit issues, proficiency testing practice 
sets and rounds, instrumented initial test facilities, urine collector/
collection site procedures, and Medical Review Officer training and 
certification. There will also be updates on a revised Federal custody 
and control form and expanded confirmatory drug test technologies.
    DTAB members and invited presenters will participate in this 
meeting through remote internet connection. On-site attendance by the 
public will be limited to space available. The meeting can also be 
accessed by the public via teleconference. To obtain teleconference 
call-in numbers and access codes, to make arrangements to attend on-
site, or to request special accommodations for persons with 
disabilities, please communicate with DTAB's Program Assistant, Ms. 
Giselle Hersh (see contact information below).
    SAMHSA would like to ensure that advisory committee meetings 
proceed in an orderly fashion, are conducted in a safe and secure 
environment, that the right of free speech is protected, and that the 
ability of SAMHSA Advisory Committees to accomplish their objectives is 
not disrupted. Therefore, the following procedures will be followed at 
all DTAB meetings:
     Attendees are subject to security screening, including 
identification (driver's license) review, metal detector screening, and 
inspection of briefcases, packages, etc. Each attendee will be issued a 
security badge that must be worn at all times while in the building.
     Any interested person who wishes to be assured of the 
right to make an oral presentation during the Public Comment portion of 
the DTAB meeting must register with Ms. Hersh before the meeting.
     Those who have not registered before the meeting will only 
be invited to speak at the discretion of the Chair and should submit 
their request to the Designated Federal Official on the day of the 
meeting.
     Public Comment participants who are designated to speak 
may be questioned only by the Chair or DTAB members.
     Audience members may not present comments or questions to 
DTAB members unless recognized by the Chair.
     Attendees at the meeting are asked to maintain order and 
not display behavior that is disruptive to the meeting (i.e., shouting 
from the audience, loud outbursts).
     We ask that attendees not approach the DTAB table area 
during the meeting without permission from the Chair or the Designated 
Federal Official.
     The DTAB Chair or Designated Federal Official will note on 
the record any disruptive behavior and will ask the person to cease the 
behavior or else leave the meeting room.
    Substantive program information, a summary of the meeting, and a 
roster of DTAB members may be obtained as

[[Page 23192]]

soon as possible after the meeting, either by accessing the SAMHSA 
Committee Web site, https://www.nac.samhsa.gov/DTAB/meetings.aspx, or 
by contacting Ms. Hersh. The transcript for the meeting will also be 
available on the SAMHSA Committee Web site within three weeks after the 
meeting.

    Committee Name: Substance Abuse and Mental Health Services 
Administration Drug Testing Advisory Board.
    Date/Time/Type: June 2, 2009 from 10 a.m. to 4:30 p.m. EDT: 
OPEN. June 3, 2009 from 10 a.m. to 1 p.m. EDT: OPEN.
    Place: Sugarloaf and Seneca Conference Rooms, 1 Choke Cherry 
Road, Rockville, Maryland 20857.
    Contact: Ms. Giselle Hersh, Program Assistant, SAMHSA Drug 
Testing Advisory Board, 1 Choke Cherry Road, Room 2-1042, Rockville, 
Maryland 20857, Telephone: 240-276-2600, Fax: 240-276-2610, E-mail: 
Giselle.Hersh@samhsa.hhs.gov.

Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health, 
Services Administration.
[FR Doc. E9-11427 Filed 5-15-09; 8:45 am]
BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.